The factors affecting a patient’s prognosis have been identified as follows: tumor size, the presence of metastases, positivity for the NTRK3 or NTRK1 fusion gene, and a late mutation event (TERT or TP53 mutation) [41]. The gene discussed is NTRK1; the disease is neoplasm.